Proposed Directors of Tirupati Graphite explain why they have requisitioned an GM. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,404.00
Bid: 11,500.00
Ask: 12,496.00
Change: 0.00 (0.00%)
Spread: 996.00 (8.661%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 12,404.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK BROKER RATINGS SUMMARY: UBS Upgrades AstraZeneca To Neutral

Mon, 30th Nov 2020 09:49

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

----------

FTSE 100

----------

UBS RAISES ASTRAZENECA TO 'NEUTRAL' (SELL) - PRICE TARGET 7,500 (7,300) PENCE

----------

BARCLAYS RAISES UNILEVER PRICE TARGET TO 5,500 (5,420) PENCE - 'OVERWEIGHT'

----------

UBS RAISES MELROSE INDUSTRIES PRICE TARGET TO 185 (134) PENCE - 'BUY'

----------

MORGAN STANLEY RAISES WHITBREAD TARGET TO 3,000 (2,700) PENCE - 'EQUAL-WEIGHT'

----------

BARCLAYS RAISES SPIRAX-SARCO PRICE TARGET TO 9,925 (9,380) PENCE - 'EQUAL WEIGHT'

----------

RBC RAISES NEXT PRICE TARGET TO 7,000 (6,500) PENCE - 'SECTOR PERFORM'

----------

RBC RAISES ASSOCIATED BRITISH FOODS PRICE TARGET TO 2,300 (2,100) PENCE - 'OUTPERFORM'

----------

RBC RAISES ANTOFAGASTA PRICE TARGET TO 1,080 (780) PENCE - 'UNDERPERFORM'

----------

RBC RAISES RIO TINTO PRICE TARGET TO 5,900 (5,000) PENCE - 'SECTOR PERFORM'

----------

RBC RAISES BHP GROUP PRICE TARGET TO 2,400 (2,000) PENCE - 'OUTPERFORM'

----------

RBC RAISES GLENCORE PRICE TARGET TO 280 (240) PENCE - 'OUTPERFORM'

----------

RBC RAISES ANGLO AMERICAN PRICE TARGET TO 3,400 (2,400) PENCE - 'OUTPERFORM'

----------

GOLDMAN SACHS CUTS AVEVA GROUP PRICE TARGET TO 3,600 (4,011) PENCE - 'NEUTRAL'

----------

GOLDMAN SACHS RAISES STANDARD LIFE ABERDEEN PRICE TARGET TO 298 (260) PENCE - 'BUY'

----------

GOLDMAN SACHS RAISES SCHRODERS PRICE TARGET TO 2,465 (2,195) PENCE - 'SELL'

----------

JEFFERIES RAISES AVIVA PRICE TARGET TO 400 (350) PENCE - 'BUY'

----------

BANK OF AMERICA RAISES AVIVA PRICE TARGET TO 375 (360) PENCE - 'NEUTRAL'

----------

JPMORGAN RAISES OCADO PRICE TARGET TO 2,000 (1,800) PENCE - 'NEUTRAL'

----------

FTSE 250

----------

RBC RAISES DUNELM GROUP TO 'OUTPERFORM' ('SECTOR PERFORM') - TARGET 1,450 PENCE

----------

RBC RAISES MARKS & SPENCER PRICE TARGET TO 145 (120) PENCE - 'OUTPERFORM'

----------

MORGAN STANLEY RAISES BEAZLEY PRICE TARGET TO 390 (350) PENCE - 'EQUAL-WEIGHT'

----------

MORGAN STANLEY RAISES LANCASHIRE PRICE TARGET TO 1,065 (1,045) P - 'OVERWEIGHT'

----------

MORGAN STANLEY RAISES HISCOX PRICE TARGET TO 1450 (990) PENCE - 'OVERWEIGHT'

----------

BARCLAYS RAISES VESUVIUS PRICE TARGET TO 500 (400) PENCE - 'EQUAL WEIGHT'

----------

BARCLAYS CUTS CARNIVAL PRICE TARGET TO 1,725 (2,250) PENCE - 'OVERWEIGHT'

----------

GOLDMAN SACHS RAISES MAN GROUP PRICE TARGET TO 140 (135) PENCE - 'NEUTRAL'

----------

GOLDMAN SACHS RAISES ASHMORE GROUP PRICE TARGET TO 435 (420) PENCE - 'BUY'

----------

JPMORGAN CUTS BODYCOTE TO 'UNDERWEIGHT' ('NEUTRAL') - TARGET 635 (670) PENCE

----------

BARCLAYS RAISES BODYCOTE PRICE TARGET TO 715 (620) PENCE - 'EQUAL WEIGHT'

----------

JPMORGAN RAISES MITCHELLS & BUTLERS TARGET TO 360 (340) PENCE - 'OVERWEIGHT'

----------

BANK OF AMERICA RAISES BALFOUR BEATTY PRICE TARGET TO 350 (345) PENCE - 'BUY'

----------

OTHER MAIN MARKET AND AIM

----------

UBS RAISES KINGSPAN GROUP PRICE TARGET TO 60 (55) EUR - 'SELL'

----------

BERENBERG RAISES VICTORIA PRICE TARGET TO 770 (330) PENCE - 'BUY'

----------

BARCLAYS CUTS NEWRIVER REIT PRICE TARGET TO 72 (76) PENCE - 'EQUAL WEIGHT'

----------

RBC RAISES CENTRAL ASIA METALS TO 'OUTPERFORM' ('SECTOR PERFORM') - TARGET 270 (170) PENCE

----------

RBC RAISES ANGLO PACIFIC GROUP PRICE TARGET TO 205 (195) PENCE - 'OUTPERFORM'

----------

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
27 Dec 2023 14:25

London close: Stocks maintain gains amid post-Christmas rally

(Sharecast News) - London's stock markets closed in positive territory on Wednesday, buoyed by a global surge in stock prices as the S&P 500 neared an all-time high on Wall Street.

Read more
27 Dec 2023 12:06

LONDON MARKET MIDDAY: Stocks hold onto gains amid US rate cut hopes

(Alliance News) - London's FTSE 100 index was outperforming other European stock-price measures at midday on Wednesday, boosted by gains for miners and industrials.

Read more
27 Dec 2023 11:20

London midday: Stocks ride global wave of post-Christmas optimism

(Sharecast News) - London's equity markets were still above the waterline at lunchtime on Wednesday, following a late Santa rally on Wall Street overnight.

Read more
27 Dec 2023 08:48

LONDON MARKET OPEN: FTSE 100 gains led by miners and industrials

(Alliance News) - Stock prices in London opened in the green on Wednesday, as hopes for US interest rate cuts in the new year continued to propel global equities higher.

Read more
27 Dec 2023 08:26

London open: FTSE takes cues from Wall Street 'Santa rally'

(Sharecast News) - London's stocks returned from the Christmas break in the green on Wednesday, boosted by a late Santa rally on Wall Street overnight.

Read more
27 Dec 2023 08:24

TOP NEWS: AstraZeneca buys Gracell to "enrich" cell therapy pipeline

(Alliance News) - AstraZeneca PLC on Tuesday said it has agreed to acquire Gracell Biotechnologies Inc, paying about USD1.2 billion for the clinical-stage company.

Read more
27 Dec 2023 07:52

LONDON BRIEFING: AstraZeneca buys Gracell Biotech; COPL CEO resigns

(Alliance News) - Stocks in London were expected to make gains at Wednesday's market open, as investors continued to pin their hopes on US interest rate cuts.

Read more
27 Dec 2023 07:02

AstraZeneca to buy Gracell Technologies for $1.2bn

(Sharecast News) - AstraZeneca on Wednesday said it was buying Gracell Biotechnologies, a global clinical-stage biopharmaceutical company developing cell therapies for the treatment of cancer and autoimmune diseases, for $1.2bn.

Read more
26 Dec 2023 21:26

Wall Street ends higher in final stretch of 2023, rate cuts in view

Intel up on $3.2 bln grant from Israel

*

Read more
26 Dec 2023 21:00

Wall Street ends higher in final stretch of 2023, rate cuts in view

Intel up on $3.2 bln grant from Israel

*

Read more
26 Dec 2023 19:41

Wall Street gains on final stretch of 2023, rate cuts in view

Intel up on $3.2 bln grant from Israel

*

Read more
22 Dec 2023 08:47

AstraZeneca, Ionis get US FDA nod for Wainua in "important milestone"

(Alliance News) - AstraZeneca PLC and Ionis Pharmaceuticals Inc on Friday celebrated the news that their drug eplontersen was approved by the US Food & Drug Administration.

Read more
22 Dec 2023 07:50

LONDON BRIEFING: UK on brink of recession as economy contracts in Q3

(Alliance News) - Stocks in London are likely to open lower on Friday, with investors feeling frosty ahead of a US inflation print this afternoon, amid sobering UK economic growth data.

Read more
22 Dec 2023 07:17

AstraZeneca gets FDA green light for nerve disease treatment

(Sharecast News) - The US Food and Drug Administration has approved the Wainua nerve disease treatment jointly developed by AstraZeneca and Ionis Pharmaceuticals.

Read more
19 Dec 2023 19:56

US adds 13 companies in China to Unverified List

WASHINGTON, Dec 19 (Reuters) - The United States has added 13 companies in China to a list of entities receiving U.S. exports that officials have been unable to inspect, according to a government notice posted on Tuesday.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.